2 research outputs found

    Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

    No full text

    1994 Annual Selected Bibliography: Asian American Studies and the Crisis of Practice

    No full text
    corecore